Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
      • División de Aviación
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Recovery Resources
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Recovery Resources
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (147)
  • Testimony (89)
  • Microgram (49)
  • Speech (19)
  • DEA Administrator Remarks (11)
  • Announcements (1)

Publication Type

  • Intelligence (63)
  • Drug Prevention (57)
  • Forensics: Quality Management System Documents (24)
  • DEA Administrator (16)
  • Announcement (1)

Drug Name

  • Narcóticos (opioides) (28)
  • Drugs of Concern (10)
  • Heroin (8)
  • Methamphetamine (7)
  • Cannabis (5)
  • Fentanyl (5)
  • Marijuana (5)
  • Designer Drugs (2)
  • Hallucinogen (2)
  • Spice/K2, Synthetic Marijuana (2)
  • Steroids (2)
  • Synthetic Opioids (2)
  • Depressants (1)
  • Ecstasy or MDMA (1)
  • Inhalant (1)
  • Stimulants (1)

Topic

  • Forensics: Quality Management System Documents (24)
  • Self Help/Personal Growth (2)
  • Family (1)
  • Forensic Sciences (1)
Clear All Results

Standard Operating Procedure for the Analysis of Suspected Natural and Synthetic Opioids

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

Standard Operating Procedure for the Analysis of Suspected Methamphetamine

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

Standard Operating Procedure for the Analysis of Suspected Cocaine

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

Standard Operating Procedure for the Analysis of Cannabis Liquids and Extracts

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

Standard Operating Procedure for the Analysis of Suspected Cannabis Plant Material

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...

DEA and FDA Issue Joint Letter to the Public on Actions to Address Shortages in Prescription Stimulants

Agosto 01, 2023
Announcements
On August 1, 2023, the Drug Enforcement Administration (DEA) and U.S. Food and Drug Administration (FDA) issued a joint letter updating the public on the ongoing prescription stimulant shortages impacting patients across the United States and actions to resolve these shortages. The DEA and FDA are committed to working together...

Statement of Anne Milgram Administrator at a Hearing Entitled Oversight of the Drug Enforcement Administration

Julio 27, 2023
DEA Administrator Remarks
Chair Biggs, Ranking Member Jackson Lee, and distinguished members of the subcommittee: On behalf of the Department of Justice (Department), and in particular the nearly 10,000 employees working at the Drug Enforcement Administration (DEA), thank you for the opportunity to appear before you today to discuss DEA’s work to save...

Protecting the U.S. Homeland: Fighting the Flow from the Southwest Border

Julio 13, 2023
Testimony
Americans today are experiencing the most devastating drug crisis in our nation’s history. This is because one drug—fentanyl—has transformed the criminal landscape. Fentanyl is exceptionally cheap to make, exceptionally easy to disguise, and exceptionally deadly to those who take it. It is the leading cause of death for Americans between...

DEA Administrator's Remarks on China-Based Chemical Manufacturing Companies and Arrests

Junio 23, 2023
DEA Administrator Remarks
“Today’s announcement is a considerable step forward in our unrelenting fight against fentanyl, targeting the threat where it starts. These companies and individuals are alleged to have knowingly supplied drug traffickers, in the United States and Mexico, with the ingredients and scientific know-how needed to make fentanyl – a drug...

Responding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act

Junio 23, 2023
Testimony
Americans today are experiencing the most devastating drug crisis in our nation’s history. This is because one drug—illicit fentanyl—has transformed the criminal landscape. Illicit fentanyl is exceptionally cheap to make, exceptionally easy to disguise, and exceptionally deadly to those who take it. It is the leading cause of death for...
Showing 1 - 10 of 317 results

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
Inicio

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster